GSK-3β1, a major substrate of AKT, not only has central functions in glycogen metabolism and insulin resistance (Wu et al., 2014) but also plays a pivotal role in Nrf2 deactivation and the initiation of oxidative injury (Xin et al., 2018). Here, AKT1 is linked to Insulin resistance.